×
Bayer Goodwill and Intangible Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
Bayer Goodwill and Intangible Assets 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$710.1B
Novo Nordisk (NVO)
$471.5B
Johnson & Johnson (JNJ)
$373.6B
AbbVie (ABBV)
$312.7B
Merck (MRK)
$250.9B
Novartis AG (NVS)
$213.1B
AstraZeneca (AZN)
$203.5B
Pfizer (PFE)
$145.4B
Sanofi (SNY)
$122.5B
Innoviva (INVA)
$1.2B